Dimensional Fund Advisors LP Trims Holdings in Personalis, Inc. (NASDAQ:PSNL)

Dimensional Fund Advisors LP cut its stake in Personalis, Inc. (NASDAQ:PSNL) by 11.9% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 75,373 shares of the company’s stock after selling 10,217 shares during the quarter. Dimensional Fund Advisors LP owned about 0.15% of Personalis worth $88,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. Public Employees Retirement System of Ohio purchased a new position in shares of Personalis in the first quarter valued at $29,000. GSA Capital Partners LLP boosted its stake in Personalis by 6.2% during the first quarter. GSA Capital Partners LLP now owns 420,141 shares of the company’s stock valued at $626,000 after buying an additional 24,498 shares during the period. Virtu Financial LLC bought a new stake in Personalis during the first quarter valued at $41,000. Price T Rowe Associates Inc. MD boosted its stake in Personalis by 58.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 95,000 shares of the company’s stock valued at $142,000 after buying an additional 34,900 shares during the period. Finally, State of Michigan Retirement System boosted its stake in Personalis by 11.3% during the first quarter. State of Michigan Retirement System now owns 493,798 shares of the company’s stock valued at $736,000 after buying an additional 50,000 shares during the period. 61.91% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on PSNL. HC Wainwright lifted their price objective on Personalis from $7.50 to $9.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Needham & Company LLC lifted their price objective on Personalis from $5.50 to $7.25 and gave the company a “buy” rating in a research note on Friday, August 16th. Finally, BTIG Research lifted their price target on Personalis from $5.50 to $7.00 and gave the stock a “buy” rating in a research note on Friday, August 16th.

Personalis Stock Up 6.6 %

Shares of PSNL stock opened at $4.87 on Wednesday. The business has a 50-day moving average price of $5.20 and a two-hundred day moving average price of $2.91. Personalis, Inc. has a 12-month low of $0.89 and a 12-month high of $7.20. The firm has a market cap of $252.94 million, a P/E ratio of -2.56 and a beta of 1.92.

Personalis (NASDAQ:PSNL) last issued its quarterly earnings results on Wednesday, August 7th. The company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.34) by $0.10. Personalis had a negative return on equity of 56.87% and a negative net margin of 101.78%. The firm had revenue of $22.58 million during the quarter, compared to analyst estimates of $19.81 million. During the same quarter in the previous year, the company posted ($0.50) earnings per share. As a group, research analysts expect that Personalis, Inc. will post -1.15 EPS for the current fiscal year.

Personalis Profile

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.